142 related articles for article (PubMed ID: 1688958)
1. [Hepatocellular carcinoma with extrahepatic malignancies].
Yoshikawa K; Mikata S; Inoue M; Amemiya A; Iwasaki T; Moriguchi S; Emoto T; Han N; Itou A
Gan No Rinsho; 1990 Jan; 36(1):23-8. PubMed ID: 1688958
[TBL] [Abstract][Full Text] [Related]
2. Management of spontaneous bleeding due to hepatocellular carcinoma.
Recordare A; Bonariol L; Caratozzolo E; Callegari F; Bruno G; Di Paola F; Bassi N
Minerva Chir; 2002 Jun; 57(3):347-56. PubMed ID: 12029230
[TBL] [Abstract][Full Text] [Related]
3. [A clinico-pathological study of hepatocellular carcinoma patients with other primary malignancies].
Miyanaga O; Miyamoto Y; Shirahama M; Ishibashi H
Gan No Rinsho; 1989 Dec; 35(15):1729-34. PubMed ID: 2558228
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis, treatment and prognosis of small hepatocellular carcinoma.
Watanabe A; Yamamoto H; Ito T; Nagashima H
Hepatogastroenterology; 1986 Apr; 33(2):52-5. PubMed ID: 3013739
[TBL] [Abstract][Full Text] [Related]
5. [Partial liver resection with small skin incision for multidisciplinary treatment of hepatocellular carcinoma].
Masutani S; Tatsuta M; Morimoto O; Ohta H; Hashimoto K; Ikeda M; Miya A; Ishida H; Kawasaki T; Furukawa H; Satomi T; Terai Y
Gan To Kagaku Ryoho; 1999 Oct; 26(12):1890-4. PubMed ID: 10560419
[TBL] [Abstract][Full Text] [Related]
6. [Clinical evaluation of PIVKA-II as a marker of hepatocellular carcinoma].
Arima K; Kodama T; Suga M; Sakamoto H; Ohe Y; Yachi A
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):3049-52. PubMed ID: 2476968
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
[TBL] [Abstract][Full Text] [Related]
8. Quantitation of alpha-fetoprotein messenger RNA for early detection of recurrent hepatocellular carcinoma: a prospective pilot study.
Schmilovitz-Weiss H; Stemmer SM; Liberzon E; Avigad S; Sulkes J; Belinki A; Kazatsker A; Ben-Ari Z
Cancer Detect Prev; 2006; 30(2):204-9. PubMed ID: 16638626
[TBL] [Abstract][Full Text] [Related]
9. [Hepatocellular carcinoma arising in the normal liver. A clinical study and long-term prognosis after surgical resection in 12 patients].
Fekete F; Belghiti J; Flejou JF; Panis Y; Molas G
Chirurgie; 1990; 116(8-9):730-4. PubMed ID: 1717205
[TBL] [Abstract][Full Text] [Related]
10. Treatment and prognosis of hepatocellular carcinoma: a population based study in France.
Borie F; Bouvier AM; Herrero A; Faivre J; Launoy G; Delafosse P; Velten M; Buemi A; Peng J; Grosclaude P; Trétarre B
J Surg Oncol; 2008 Dec; 98(7):505-9. PubMed ID: 18932235
[TBL] [Abstract][Full Text] [Related]
11. Hepatic resection for hepatocellular carcinoma in elderly patients.
Yeh CN; Lee WC; Jeng LB; Chen MF
Hepatogastroenterology; 2004; 51(55):219-23. PubMed ID: 15011868
[TBL] [Abstract][Full Text] [Related]
12. Early diagnosis of hepatocellular carcinoma.
Okazaki N; Yoshino M; Yoshida T; Takayasu K; Moriyama N; Makuuchi M; Yamazaki S; Hasegawa H; Noguchi M; Hirohashi S
Hepatogastroenterology; 1990 Oct; 37(5):480-3. PubMed ID: 1701411
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of 293 cases of hepatocellular carcinoma of recent ten years--II. Diagnosis, therapy and prognosis].
Miyanaga O; Miyamoto Y; Jyo R; Nakao T; Koga T; Saito S; Koyanagi K; Yamaguchi S; Endo M; Shirahama M
Fukuoka Igaku Zasshi; 1989 Nov; 80(11):495-502. PubMed ID: 2556337
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.
Soresi M; Magliarisi C; Campagna P; Leto G; Bonfissuto G; Riili A; Carroccio A; Sesti R; Tripi S; Montalto G
Anticancer Res; 2003; 23(2C):1747-53. PubMed ID: 12820452
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic efficacy of transcatheter arterial embolization of primary hepatocellular carcinoma: discrepancy in different histopathologic subtypes.
Wang Y; Zhang J; Gao Y; Yu M; Gong Y; Yu G
Chin Med J (Engl); 1999 Mar; 112(3):264-8. PubMed ID: 11593564
[TBL] [Abstract][Full Text] [Related]
16. Markers for hepatocellular carcinoma.
Wu AH; Sell S
Immunol Ser; 1990; 53():403-22. PubMed ID: 1713067
[TBL] [Abstract][Full Text] [Related]
17. Monitoring of lectin-reactive alpha-fetoproteins in patients with hepatocellular carcinoma treated using transcatheter arterial embolization.
Yamashita F; Tanaka M; Satomura S; Tanikawa K
Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):627-33. PubMed ID: 8590157
[TBL] [Abstract][Full Text] [Related]
18. [Hepatocellular carcinoma in Germany. Epidemiology, etiology, clinical aspects and prognosis in 100 consecutive patients of a university clinic].
Petry W; Heintges T; Hensel F; Erhardt A; Wenning M; Niederau C; Häussinger D
Z Gastroenterol; 1997 Dec; 35(12):1059-67. PubMed ID: 9487638
[TBL] [Abstract][Full Text] [Related]
19. Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer.
Marelli L; Shusang V; Buscombe JR; Cholongitas E; Stigliano R; Davies N; Tibballs J; Patch D; Meyer T; Burroughs AK
J Nucl Med; 2009 Jun; 50(6):871-7. PubMed ID: 19443599
[TBL] [Abstract][Full Text] [Related]
20. Alpha-fetoprotein in the early diagnosis of hepatocellular carcinoma.
Ballesta AM; Calvet X; Filella X; Bruix J; Bru C; Molina R; Rodes J
J Nucl Med Allied Sci; 1989; 33(3 Suppl):39-41. PubMed ID: 2480420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
